Dec 15 (Reuters) - Swiss pharmaceutical manufacturer Lonza Group AG said on Thursday it is buying Capsugel, a U.S. maker of capsule products and other drug delivery systems, for $5.5 billion in cash. ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results